Modulation of human cytochrome P450 1B1 expression by 2,4,3′, 5′-tetramethoxystilbene

Drug Metabolism and Disposition

Volumn 33, Issue 12, 2005, Pages 1771-1776

  Chun, Young Jin ^a   Lee, Sang Kwang ^a   Mie, Young Kim ^a  

^a Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,4,3',5' TETRAMETHOXYSTILBENE; 7,12 DIMETHYLBENZ[A]ANTHRACENE; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1B1; ETHOXYRESORUFIN DEETHYLASE; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CELL DEATH; CELL STRAIN HL 60; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME INHIBITION; GENE EXPRESSION; INCUBATION TIME; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PLANT EXTRACTS; STILBENES; TETRACHLORODIBENZODIOXIN;

ANIMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 28144462666     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.105.006502     Document Type: Article

References (38)

1. Burke MD, Thompson S, Elcombe CR, Halpert J, Haaparanta T, and Mayer RT (1985) Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol 34:3337-3345.
2. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, and Savouret JF (1999) Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 56:784-790.
3. Chang TK, Lee WB, and Ko HH (2000) Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1. Can J Physiol Pharmacol 78:874-881.
4. Chen ZH, Hurh YJ, Na HK, Kim JH, Chun YJ, Kim DH, Kang KS, Cho MH, and Surh YJ (2004) Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis 25:2005-2013.
5. Chun YJ, Kim MY, and Guengerich FP (1999) Resveratrol is a selective human cytochrome P450 1A1 inhibitor. Biochem Biophys Res Commun 262:20-24.
6. Chun YJ and Kim S (2003) Discovery of cytochrome P450 1B1 inhibitors as new anti-cancer agents. Med Res Rev 23:657-668.
7. Chun YJ, Kim S, Kim D, Lee SK, and Guengerich FP (2001a) A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res 61:8164-8170.
8. Chun YJ, Ryu SY, Jeong TC, and Kim MY (2001b) Mechanism-based inhibition of human cytochrome P450 1A1 by rhapontigenin. Drug Metab Dispos 29:389-393.
9. Ciolino HP, Daschner PJ, and Yeh GC (1998) Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res 58:5707-5712.
10. Clement MV, Hirpara JL, Chawdhury SH, and Pervaiz S (1998) Chemopreventive agent resveratrol, a natural product derived from grapes, triggers CD95 signaling-dependent apoptosis in human tumor cells. Blood 92:996-1002.
11. Estrov Z, Shishodia S, Faderl S, Harris D, Van Q, Kantarjian HM, Talpaz M, and Aggarwal BB (2003) Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kB, inhibits proliferation, causes S-phase arrest and induces apoptosis of acute myeloid leukemia cells. Blood 102:987-995.
12. Geahlen RL and McLaughlin JL (1989) Piceatannol (3,4,3′,5- tetrahydroxy-trans-stilbene) is a naturally occurring protein-tyrosine kinase inhibitor. Biochem Biophys Res Commun 165:241-245.
13. Guengerich FP, Martin MV, Guo Z, and Chun YJ (1996) Purification of functional recombinant P450s from bacteria. Methods Enzymol 272:35-44.
14. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ, and Sutter TR (1996) 17β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc Natl Acad Sci USA 93:9776-9781.
15. Huang C, Ma WY, Goranson A, and Dong Z (1999) Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20:237-242.
16. Kim S, Ko H, Park JE, Jung S, Lee SK, and Chun YJ (2002) Design, synthesis and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors. J Med Chem 45:160-164.
17. Lee SH, Ryu SY, Kim HB, Kim MY, and Chun YJ (2002) Induction of apoptosis by 3,4′-dimethoxy-5-hydroxystilbene in human promyeloid leukemic HL-60 cells. Planta Med 68:123-127.
18. Lee SK, Kim Y, Kim MY, Chun YJ, and Kim S (2004) Potent inhibition of recombinant human cytochrome P-450 1A1 by pentamethoxystilbene. J Toxicol Environ Health A 67:1987-2000.
19. Li JJ and Li SA (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 46:1858-1863.
20. Li W, Harper PA, Tang BK, and Okey AB (1998) Regulation of cytochrome P450 enzymes by aryl hydrocarbon receptor in human cells: CYP1A2 expression in the LS180 colon carcinoma cell line after treatment with 2,3,7,8- tetrachlorodibenzo-p-dioxin or 3-methylcholanthrene. Biochem Pharmacol 56:599-612.
21. Liehr JG (1997) Dual role of oestrogens as hormones and pro-carcinogens: tumor initiation by metabolic activation of oestrogens. Eur J Cancer Prev 6:3-10.
22. Liehr JG, Fang WF, Sirbasku DA, and Ari-Ulubelen A (1986) Carcinogenicity of catechol estrogens in Syrian hamsters. J Steroid Biochem 24:353-356.
23. Ma X, Idle JR, Krausz KW, and Gonzalez FJ (2005) Metabolism of melatonin by human cytochromes P450. Drug Metab Dispos 33:489-494.
24. McKay JA, Melvin WT, Ah-See AK, Ewen SWB, Greenlee WF, Marcus CB, Burke MD, and Murray GI (1995) Expression of cytochrome P450 CYP1B1 in breast cancer. FEBS Lett 374:270-272.
25. Murray GI, Taylor MC, McFadyen MC, McKay JA, Greenlee WF, Burke MD, and Melvin WT (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57:3026-3031.
26. Omura T and Sato R (1964) The carbon-monoxide binding pigment of liver microsomes. J Biol Chem 239:2370-2378.
27. Parikh A, Gillam EMJ, and Guengerich FP (1997) Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat Biotechnol 15:784-788.
28. Savas U, Bhattacharyya KK, Christou M, Alexander DL, and Jefcoate CR (1994) Mouse cytochrome P-450EF, representative of a new 1B subfamily of cytochrome P-450s. Cloning, sequence determination and tissue expression. J Biol Chem 269:14905-14911.
29. Shen Z, Liu J, Wells RL, and Elkind MM (1994) cDNA cloning, sequence analysis and induction by aryl hydrocarbons of a murine cytochrome P450 gene, CYP1B1. DNA Cell Biol 13:763-769.
30. Shimada T, Gillam EMJ, Sutter TR, Strickland PT, Guengerich FP, and Yamazaki H (1997) Oxidation of xenobiotics by recombinant human cytochrome P450 1B1. Drug Metab Dispos 29:617-622.
31. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, and Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 56:2979-2984.
32. Shimada T, Watanabe J, Kawajiri K, Sutter TR, Guengerich FP, Gillam EMJ, and Inoue K (1999) Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis 20:1607-1613.
33. Sutter TR, Guzman K, Dold KM, and Greenlee WF (1991) Targets for dioxin: genes for plasminogen activator inhibitor-2 and interleukin-1. Science (Wash DC) 254:415-418.
34. Sutter TR, Tang YM, Hayes CL, Wo YY, Jabs EW, Li X, Yin H, Cody CW, and Greenlee WF (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269:13092-13099.
35. Tang YM, Wo YY, Stewart J, Hawkins AL, Griffin CA, Sutter TR, and Greenlee WF (1996) Isolation and characterization of the human CYP1B1 gene. J Biol Chem 271:28324-28330.
36. Walker NJ, Gastel JA, Costa LT, Clark GC, Lucier GW, and Sutter TR (1995) Rat CYP1B1: an adrenal cytochrome P450 that exhibits sex-dependent expression in livers and kidneys of TCDD-treated animals. Carcinogenesis 16:1319-1327.
37. Wo YY, Stewart J, and Greenlee WF (1997) Functional analysis of the promoter for the human CYP1B1 gene. J Biol Chem 272:26702-26707.
38. Wolter F, Clausnitzer A, Akoglu B, and Stein J (2002) Piceatannol, a natural analog of resveratrol, inhibits progression through the S phase of the cell cycle in colorectal cancer cell lines. J Nutr 132:298-302.